Antibodies And Fragments Thereof Raised Against The Alpha-3 Domain Of Hla-G Protein, Methods And Means For Their Preparation, And Uses Thereof - EP2917229

The patent EP2917229 was granted to Invectys on Jan 8, 2020. The application was originally filed on Nov 12, 2013 under application number EP13791794A. The patent is currently recorded with a legal status of "Revoked".

EP2917229

INVECTYS
Application Number
EP13791794A
Filing Date
Nov 12, 2013
Status
Revoked
Nov 25, 2022
Grant Date
Jan 8, 2020
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

F HOFFMANN LA ROCHEOct 8, 2020VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBBADMISSIBLE
JAMES POOLEOct 8, 2020CARPMAELS & RANSFORDADMISSIBLE
HUTTEROct 7, 2020HUTTERADMISSIBLE
REGIMBEAUOct 6, 2020-ADMISSIBLE

Patent Citations (16) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
EXAMINATIONUS2007259403
EXAMINATIONWO0222784
INTERNATIONAL-SEARCH-REPORTWO2010150235
INTERNATIONAL-SEARCH-REPORTWO9942128
OPPOSITIONCN101967191
OPPOSITIONCN1718588
OPPOSITIONEP1054688
OPPOSITIONUS2007020703
OPPOSITIONUS2007259403
OPPOSITIONWO0222784
OPPOSITIONWO2010150233
OPPOSITIONWO2010150235
OPPOSITIONWO2013106586
OPPOSITIONWO2014072534
OPPOSITIONWO2017207775
OPPOSITIONWO9942128

Non-Patent Literature (NPL) Citations (97) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
EXAMINATION- Mitsunori Shiroishi ET AL, "Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2LIR2ILT4CD85d)", and approved August, (20060101), URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1637596/pdf/zpq16412.pdf, XP055484035
EXAMINATION- Siyuan Liang ET AL, "HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor", European Journal of Immunology, Weinheim, (20020901), vol. 32, no. 9, doi:10.1002/1521-4141(200209)32:9<2418::AID-IMMU2418>3.0.CO;2-L, ISSN 0014-2980, pages 2418 - 2426, XP055585824
EXAMINATION- LAURE LOUMAGNE ET AL, "In vivo evidence that secretion of HLA-G by immunogenic tumor cells allows their evasion from immunosurveillance : Soluble HLA-G Mediates Tumor Escape In Vivo", INTERNATIONAL JOURNAL OF CANCER, US, (20141101), vol. 135, no. 9, doi:10.1002/ijc.28845, ISSN 0020-7136, pages 2107 - 2117, XP055499676
EXAMINATION- CAROSELLA EDGARDO D ET AL, "Beyond the increasing complexity of the immunomodulatory HLA-G molecule", BLOOD, AMERICAN SOCIETY OF HEMATOLOGY, US, vol. 111, no. 10, doi:10.1182/BLOOD-2007-12-127662, ISSN 0006-4971, (20080515), pages 4862 - 4870, (20080311), XP008104444
INTERNATIONAL-SEARCH-REPORT- TANABE M ET AL, "STRUCTURAL AND FUNCTIONAL ANALYSIS OF MONOMORPHIC DETERMINANTS RECOGNIZED BY MONOCLONAL ANTIBODIES REACTING WITH THE HLA CLASS I ALPHA-3 DOMAIN", JOURNAL OF IMMUNOLOGY, (1992), vol. 148, no. 10, ISSN 0022-1767, pages 3202 - 3209, XP002692766 [A] 1-23 * the whole document *
INTERNATIONAL-SEARCH-REPORT- LEE N ET AL, "The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association", IMMUNITY 1995 US, (1995), vol. 3, no. 5, ISSN 1074-7613, pages 591 - 600, XP002720273 [Y] 10-16,19-21 * page 597, column left, paragraph 4 - column right, paragraph 1 *
INTERNATIONAL-SEARCH-REPORT- ROUAS-FREISS ET AL, "Expression of tolerogenic HLA-G molecules in cancer prevents antitumor responses", SEMINARS IN CANCER BIOLOGY, SAUNDERS SCIENTIFIC PUBLICATIONS, PHILADELPHIA, PA, US, (20071109), vol. 17, no. 6, doi:10.1016/J.SEMCANCER.2007.07.003, ISSN 1044-579X, pages 413 - 421, XP022338887 [Y] 1-23 * abstract * * page 419, column left, paragraph 4 - column right, paragraph 1 *
INTERNATIONAL-SEARCH-REPORT- PAUL PASCALE ET AL, "HLA-G, -E, -F preworkshop: Tools and protocols for analysis of non-classical class I genes transcription and protein expression", HUMAN IMMUNOLOGY, (200011), vol. 61, no. 11, ISSN 0198-8859, pages 1177 - 1195, XP002692764 [Y] 1-23 * the whole document *
INTERNATIONAL-SEARCH-REPORT- MENIER C ET AL, "Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: New tools to analyze the expression of nonclassical HLA class I molecules", HUMAN IMMUNOLOGY, NEW YORK, NY, US, (20030301), vol. 64, no. 3, doi:10.1016/S0198-8859(02)00821-2, ISSN 0198-8859, pages 315 - 326, XP002321005 [Y] 1-23 * the whole document *
INTERNATIONAL-SEARCH-REPORT- YE SHANG-RONG ET AL, "Human leukocyte antigen G expression: as a significant prognostic indicator for patients with colorectal cancer", MODERN PATHOLOGY, (200703), vol. 20, no. 3, ISSN 0893-3952, pages 375 - 383, XP002720274 [Y] 15,17,19 * page 376, column right, paragraph 2 *
INTERNATIONAL-SEARCH-REPORT- MCCLUSKEY ET AL., "Crystal structure of HLA-G: A nonclassical MHC class / molecule expressed at the fetal-maternal interface", PNAS, (2005), vol. 102, no. 9, pages 3360 - 3365, XP003007722 [AD] 1-23 * the whole document *
INTERNATIONAL-SEARCH-REPORT- VAN LIEROP M J C ET AL, "Detection of HLA-G by a specific sandwich ELISA using monoclonal antibodies G233 and 56B.", MOLECULAR HUMAN REPRODUCTION AUG 2002, (200208), vol. 8, no. 8, ISSN 1360-9947, pages 776 - 784, XP002692763 [Y] 1-23 * the whole document *
INTERNATIONAL-SEARCH-REPORT- AGAUGUE SOPHIE ET AL, "Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus Th1/Th17", BLOOD, (201106), vol. 117, no. 26, pages 7021 - 7031, XP002692762 [I] 1-23 * the whole document * [Y] 1-23
INTERNATIONAL-SEARCH-REPORT- DESAI S A ET AL, "Structural relatedness of distinct determinants recognized by monoclonal antibody TP25.99 on beta 2-microglobulin-associated and beta 2-microglobulin-free HLA class I heavy chains.", JOURNAL OF IMMUNOLOGY (BALTIMORE, MD. : 1950) 15 SEP 2000, (20000915), vol. 165, no. 6, ISSN 0022-1767, pages 3275 - 3283, XP002692765 [A] 1-23 * the whole document *
OPPOSITION- "Ab7759 Data Sheet", ABCAM, UK
OPPOSITION- AGAUGUE, S. et al., Blood, (20110000), vol. 117, no. 26, pages 7021 - 7031
OPPOSITION- Akiko Ishitani , Noriko Sageshima, Ni Lee, Natalia Dorofeeva, Katsuhiko Hatake, Hans Marquardt, Daniel E Geraghty, "Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition", J. Immunol., (20030000), vol. 171, no. 2003, pages 1376 - 1384, XP002522133
OPPOSITION- Atsushi Furukawa, Manami Meguro 1,T, Rika Yamazaki1, Hiroshi Watanabe 1, Ami Takahashi1 , Kimiko Kuroki1 And Katsumi Maenaka, "Evaluation of the Reactivity and Receptor Competition of HLA-G Isoforms toward AvailableAntibodies: Implications of Structural Characteristics of HLA-G Isoforms", Int. J. Mol. Sci., (20190000), vol. 20, page 5947, XP055741666
OPPOSITION- C. Seitz, B. Uchanska-Ziegler, A. Zank, A. Ziegler, "The monoclonal antibody HCA2 recognises a broadly shared epitope on selected classical as well as several non-classicalHLA class I molecules", Molecular Immunology, (1998), pages 819 - 827, XP055741695
OPPOSITION- DIAZ-LAGARES, A. et al., "Nitric oxide produces HLA-G nitration and inducesmetalloprotease-dependent shedding creating a tolerogenic milieu", Immunology, (20080000), vol. 126, no. 3, pages 436 - 445, XP055741665
OPPOSITION- FURUKAWA, A. et al., "Evaluation of the Reactivity and Receptor Competition of HLA-G Isoforms toward AvailableAntibodies: Implications of Structural Characteristics of HLA-G Isoforms", Int. J. Mol. Sci., vol. 20, page 5947, XP055741666
OPPOSITION- GAUSTER, M. et al., "Letters to the Editor", Rheumatology, (20070000), vol. 46, pages 892 - 893, XP055741682
OPPOSITION- GONEN-GROSS et al., "COMPLEXES OF HLA-G PROTEIN ON THE CELL SURFACE ARE IMPORTANT FOR LEUKOCYTE IG-LIKE RECEPTOR-1 FUNCTION", J. Immunol., (20030000), vol. 171, pages 1343 - 1351, XP008043177
OPPOSITION- ISHITANI A et al., "Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition", J Immunol., (20030801), vol. 171, no. 3, pages 1376 - 1384, XP002522133
OPPOSITION- ISHITANI AKIKO; ET AL, "Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition", J. Immunol., (20030000), vol. 171, pages 1376 - 1384, XP002522133
OPPOSITION- Kaw Yan Chua, John D.A. Ramos, And Nge Cheong, "Chapter 40 Production of Monoclonal Antibody by DNA Immunization with Electroporation", Kaw Yan Chua, John D.A. Ramos, And Nge Cheong, S.Li, Electroporation Protocols: Preclinical and Clinical Gene Medicine, Humana Press, (20080000), vol. 423, pages 509 - 520, XP055741950
OPPOSITION- LIN, A. et al., "HLA-G expression in human ovarian carcinomacounteracts NK cell function", Annals of Oncology, (20070000), vol. 18, no. 11, pages 1804 - 1809, XP055741670
OPPOSITION- LIN et al., "HLA-G expression in human ovarian carcinomacounteracts NK cell function", Annals of Oncology, (20070000), vol. 18, no. 2007, pages 1804 - 1809, XP055741670
OPPOSITION- LOKE, Y. W. et al., "Evaluation of trophoblast HLA-G antigenwith a specific monoclonal antibody", Tissue Antigens, (19970000), vol. 50, pages 135 - 146, XP055741707
OPPOSITION- MARKEL, G. et al., "Preclinical Evaluation of Adoptive Cell Therapy for Patients with Metastatic Renal Cell Carcinoma", Anticancer Res., (20090000), vol. 29, pages 145 - 154, XP055741669
OPPOSITION- Michael Mcmaster; Zhou Yan; Shorter Simon; Kapasi Kubra; Geraghty Dan; Lim Kee-Hak; Fisher Susan, "HLA-G Isoforms Produced by Placental Cytotrophoblasts and Found in Amniotic Fluid Are Due to Unusual Glycosylation", J. Immunol., (19980000), vol. 160, no. 12, pages 5922 - 5928, XP055741850
OPPOSITION- Michael Mcmaster, Zhou Yan, Shorter Simon, Kapasi Kubra, Geraghty Dan, Lim Kee-Hak, Fisher Susan, "HLA-G isoforms produced by placental cytotrophoblasts and found in amniotic fluid are due to unusual glycosylation", J Immunol., (19980615), vol. 160, no. 12, pages 5922 - 5928, XP055741850
OPPOSITION- "Mouse anti Human HLA Class I Heavy Chain (Restricted expression)", Nordlc-MUbIO
OPPOSITION- Murphy K., Paul Travers, Mark Walport, JANEWAY's Immunobiology, (20080000), page 735, XP055746840
OPPOSITION- Paola Contini; Ghio Massimo; Poggi Alessandro; Filaci Gilberto; Indiveri Francesco; Ferrone Soldano; Puppo Francesco, "Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation", Eur. J. Immunol., (20030000), vol. 33, no. 1, pages 125 - 134, XP055485559
OPPOSITION- S HIROISHI, M. et al., "Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2LIR2ILT4CD85d", PNAS, (20060000), vol. 103, no. 44, pages 16412 - 16417, XP055484035
OPPOSITION- Shiroishi Mitsunori , Kimiko Kuroki, Linda Rasubala, Kouhei Tsumoto, Izumi Kumagai, Eiji Kurimoto, Koichi Kato, Daisuke Kohda, Katsumi Maenaka, "Structural basis for recognition of the nonclassical MHC molecule HLA-G by the leukocyte Ig-like receptor B2 (LILRB2/LIR2/ILT4/CD85d)", PNAS, (20060000), vol. 103, no. 2006, pages 16412 - 16417, XP055484035
OPPOSITION- Smruti A Desai; ET AL, "Structural Relatedness of Distinct Determinants Recognized by Monoclonal Antibody TP25.99 on b2-Microglobulin-Associated and b2-Microglobulin-Free HLA Class I Heavy", The Journal of Immunology,, (20000000), vol. 165, pages 3275 - 3283, XP007909559
OPPOSITION- TANABE M; ET AL, "STRUCTURAL AND FUNCTIONAL ANALYSIS OF MONOMORPHIC DETERMINANTS RECOGNIZED BY MONOCLONAL ANTIBODIES REACTING WITH THE HLA CLASS I ALPHA-3 DOMAIN", Journal of Immunology, (19920000), vol. 148, no. 10, pages 3202 - 3209, XP002692766
OPPOSITION- "The Immunology of DMA Vaccines", DNA Vaccines: Methods and Protocols, (20000000), pages 37 - 38, XP055741718
OPPOSITION- ZOLLER et al., "Prophylactic tumor vaccination: comparison of effector mechanisms initiated by protein versus DNA vaccination", J. Immunol., (20010000), vol. 166, no. 2001, pages 3440 - 3450, XP055746836
OPPOSITION- Siyuan Liang , Boris Baibakov, Anatolij Horuzsko, "HLA-G inhibits the functions of murine dendritic cells via the PIR-B immune inhibitory receptor", Eur. J. Immunol., (20020000), vol. 32, no. 2002, pages 2418 - 2426, XP055585824
OPPOSITION- Solène Le Rond; Joël Le Maoult; Caroline Créput; Catherine Menier; Marina Deschamps; Gaëlle Le Friec; Laurence Amiot; Antoine Durrbach; Jean Dausset; Edgardo d Carosella; Nathalie Rouas-Freiss, "Alloreactive CD 4+ and CD 8+ T cells express the immunotolerant HLA-G molecule in mixed lymphocyte reactions: in vivo implications in transplanted patients", European Journal of Immunology,, (20040300), vol. 34, no. 3, pages 649 - 660, XP055485405
OPPOSITION- Eduardo A. Donadi ET AL, "Implications of the polymorphism of HLA-G on its function,regulation, evolution and disease association", Cell. Mol. Life Sei, (2011), vol. 68, pages 369 - 395, XP019873563
OPPOSITION- Barnstable C J; Bodmer W F; Brown G; Galfre G; Milstein C; Williams A F; Ziegler A, "Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis", Cell, (19780500), vol. 14, no. 1, pages 9 - 20, XP023909919
OPPOSITION- Angal S; King D J; Bodmer M W; Turner A; Lawson A D G; Roberts G; Pedley B; Adair J R, "A single amino acid substitution abolishes the heterogeneity of chimeric mouse/human (IgG4) antibody", MOLECULAR IMMUNOLOGY,, (19930100), vol. 30, no. 1, pages 105 - 8, XP023683005
OPPOSITION- LEE, N. et al., "The Membrane-Bound and Soluble Forms of HLA-G Bind Identical Sets of Endogenous Peptides but Differ with Respect to TAP Association", Immunity, (19950000), vol. 3, no. 5, pages 591 - 600, XP002720273
OPPOSITION- LEE N et al., "The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association", Immunity, (19951100), vol. 3, no. 5, pages 591 - 600, XP002720273
OPPOSITION- Lee N, Malacko A R, Ishitani A, Chen M C, Bajorath J, Marquardt H, Geraghty D E, "The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association", Immunity, (19950000), vol. 3, no. 5, pages 591 - 600, XP002720273
OPPOSITION- Lee N; Malacko A R; Ishitani A; Chen M C; Bajorath J; Marquardt H; Geraghty D E, "The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association", Immunity, (19950000), vol. 3, no. 5, pages 591 - 600, XP002720273
OPPOSITION- KOBAYASHI, Y. et al., "Establishment of a Choriocarcinoma Model from Immortalized Normal Extravillous Trophoblast Cells Transduced with HRASV12", Am. J. Pathol., (20110000), vol. 179, no. 3, pages 1471 - 1482, XP055354554
OPPOSITION- Naji; Durrbach A; Carosella A; Rouas-Freiss E D; N, "Soluble HLA-G and HLA-G1 expressing antigen-presenting cells inhibit T- cell alloproliferation through ILT- 2/ILT-4/FasL-mediated pathways", HUMAN IMMUNOLOGY,, (20070400), vol. 68, no. 4, pages 233 - 239, XP022201652
OPPOSITION- CAROSELLA et al., "HLA-G: from biology to clinical benefits Trends", Immunology, (20080000), vol. 29, no. 3, pages 125 - 132, XP055198574
OPPOSITION- Apps R; Gardner L; Moffett A, "A critical look at HLA-G", TRENDS IN IMMUNOLOGY,, (20080700), vol. 29, no. 7, pages 313 - 321, XP022765471
OPPOSITION- CHAPLIN DD, "Overview of the immune response", J Allergy Clin Immunol, (20100200), vol. 125, no. 2 Suppl 2, pages S3 - S23, XP026914602
OPPOSITION- Rouas-Freiss; Moreau N; Menier P; LeMaoult C; Carosella J; E D, "Expression of tolerogenic HLA-G molecules in cancer prevents antitumor responses", Seminars in Cancer Biology, (20070000), vol. 17, no. 6, pages 413 - 421, XP022338887
OPPOSITION- ROUAS-FREISS, N. et al., "Expression of tolerogenic HLA-G molecules in cancer prevents antitumor responses", Seminars in Cancer Biol, (20070000), vol. 17, pages 413 - 421, XP022338887
OPPOSITION- PAUL PASCALE; ET AL, "HLA-G, -E, -F preworkshop: Tools and protocols for analysis of non-classical class I genes transcription and protein expression", Human Immunology, (20000000), vol. 61, no. 11, pages 1177 - 1195, XP002692764
OPPOSITION- Catherine Menier; Berta Saez; Vaclav Horejsi; Silvia Martinozzi; Irene Krawice-Radanne; Sylvie Bruel; Caroline Le Danff; Murielle Reboul; Ivan Hilgert; Michèle Rabreau; Mur Luis Larrad; Marika Pla; Edgardo D Carosella; Nathalie Rouas-Freiss, "Characterization of Monoclonal Antibodies Recognizing HLA-G or HLA-E: New Tools to Analyze the Expression of Nonclassical HLA Class I Molecules", Human Immunology, (20030000), vol. 64, pages 315 - 326, XP055365555
OPPOSITION- MENIER, C. et al., "Characterization of Monoclonal Antibodies Recognizing HLA-G or HLA-E: New Toolsto Analyze the Expression of Nonclassical HLA Class I Molecules", Human Immunol, (20030000), vol. 64, pages 315 - 326, XP055365555
OPPOSITION- MENIER et al., "Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: New tools to analyze the expression of nonclassical HLA class I molecules", Human Immunology, (20030000), vol. 64, no. 3, pages 315 - 326, XP002321005
OPPOSITION- Pirrone F., Roxana E. Iacob, John R. Engen, "Applications of hydrogen/deuterium exchange MS from 2012 to 2014", Analytical Chemistry, (20150000), vol. 87, pages 99 - 118, XP055746626
OPPOSITION- FOURNEL S et al., "Comparative reactivity of different HLA-G monoclonal antibodies to soluble HLA-G molecules", Tissue Antigens, (20000600), vol. 55, no. 6, pages 510 - 518, XP000989580
OPPOSITION- MANSFIELD, A. S. et al., "Regional immunity in melanoma: immunosuppressive changes precede nodal metastasis", Modern Pathol., (20110000), vol. 24, pages 487 - 494, XP055741663
OPPOSITION- Ye S R; Yang H; Li K; Dong D D; Lin X M; Yie S M, "Human leukocyte antigen G expression: as a significant prognostic indicator for patients with colorectal cancer", Modern Pathology, (20070000), vol. 20, no. 3, pages 375 - 383, XP002720274
OPPOSITION- Kutzler Michele A; Weiner David B, "DNA vaccines: ready for prime time?", NATURE REVIEWS GENETICS,, (20081000), vol. 9, no. 10, pages 776 - 788, XP037134884
OPPOSITION- CLEMENTS, C. S. et al., "Crystal structure of HLA-G: a nonclassical MHC class I molecule expressed at the fetalmaternal interface", PNAS, (20050000), vol. 102, no. 9, pages 3360 - 3365, XP003007722
OPPOSITION- CLEMENTS et al., "Crystal structure of HLA-G: a nonclassical MHC class I molecule expressed at the fetalmaternal interface", PNAS, (20050000), vol. 102, no. 9, pages 3360 - 3365, XP003007722
OPPOSITION- BOYSON, J. E. et al., "Disulfide bond-mediated dimerization of HLA-G on the cell surface", PNAS, (20020000), vol. 99, no. 25, pages 16180 - 16185, XP003007725
OPPOSITION- GERAGHTY, D.E. et al., "A human major histocompatibility complex class I gene that encodes a protein with shortened cytoplasmic segment", Proc. Natl. Acad. Sci. USA, vol. 84, no. 1, pages 9145 - 9149, XP002007029
OPPOSITION- BENSUSSAN, A. et al., "Detection of membrane-bound HLA-G translated products with aspecific monoclonal antibody", PNAS, (19950000), vol. 92, pages 10292 - 10296, XP002007033
OPPOSITION- PAUL, P. et al., "HLA-G EXPRESSION IN MELANOMA: A WAY FOR TUMOR CELLS TO ESCAPE FROM IMMUNOSURVEILLANCE", PNAS, (19980000), vol. 95, no. 8, pages 4510 - 4515, XP002100587
OPPOSITION- Matsushita Haruka, Shota Endo, Eiji Kobayashi, Yuzuru Sakamoto, Keisuke Kobayashi, Kohji Kitaguchi, Kimiko Kuroki, Arvid Söderhäll,‖ Katsumi Maenaka, Akira Nakamura, Stephen M. Strittmatter, And Toshiyuki Tak, "Differential but Competitive Binding of Nogo Protein and Class I Major Histocompatibility Complex (MHCI) to the PIR-B Ectodomain Provides an Inhibition of Cells", J. Biol. Chem., (20110602), vol. 286, no. 29, pages 25739 - 25747, XP055746826
OPPOSITION- SHIROISHI, M. et al., "Efficient leukocyte Ig-like receptor signaling and crystal structure of disulfide-linked HLA-G dimer", J. Biol. Chem., (20060000), vol. 281, no. 15, pages 10439 - 10447, XP003007724
OPPOSITION- LADDY DOMINICK J; WEINER DAVID B, "From Plasmids to Protection: A Review of DNA Vaccines Against Infectious Diseases", International Reviews of Immunology, (20060000), vol. 25, pages 99 - 123, XP009079996
OPPOSITION- YARI, F. et al., "Production and Characterization of Monoclonal Antibodies with Specificity for Human HLA-G Isoforms", Hybridoma and Hybridomics, (20030000), vol. 22, no. 5, pages 301 - 306, XP055741678
OPPOSITION- A. Nencioni, F. Gruenebach , F. Patrone & P. Brossart, "Anticancer vaccination strategies", Annals of Oncology, (20040000), vol. 15, no. Suppl 4, pages iv153 - iv160, XP055741955
OPPOSITION- VAN LIEROP et al., "Detection of HLA-G by a specific sandwich ELISA using monoclonal antibodies G233 and 56B", Molecular Human Reproduction, (20020000), vol. 8, no. 8, pages 776 - 784, XP002692763
OPPOSITION- VAN LIEROP, M. et al., "Detection of HLA-G by a specific sandwich ELISA using monoclonal antibodies G233 and 56B", Mol. Hum. Reprod., (20020000), vol. 8, no. 8, pages 776 - 784, XP002692763
OPPOSITION- VAN LIEROP MJ et al., "Detection of HLA-G by a specific sandwich ELISA using monoclonal antibodies G233 and 56B", Molecular Human Reproduction,, (20020000), vol. 8, no. 8, pages 776 - 784, XP002692763
OPPOSITION- LE DISCORDE, M. et al., "HLA-G*0105N Null Allele Encodes Functional HLA-G Isoforms1", Biology of Reprod., (20050000), vol. 73, pages 280 - 288, XP055741667
OPPOSITION- Magali Le Discorde, Caroline Le Danff, Philippe Moreau, Nathalie Rouas-Freiss, Edgardo D. Carosella, "HLA-G*0105N null allele encodes functional HLA-G isoforms", Biology of Reproduction, (20050800), vol. 73, no. 2, pages 280 - 288, XP055741841
OPPOSITION- PARISH, D. C. et al., "IMMUNOGENICITY OF LOW-DOSE INTRADERMAL RECOMBINANT DNA HEPATITIS B VACCINE", Southern Med. J., (19910000), vol. 84, no. 4, pages 426 - 430, XP009055450
OPPOSITION- Y. Xing, K. A. Hogquist, "T- cell tolerance: central and peripheral", Cold Spring Harb Perspect Biol, (20120601), vol. 4, no. 6, page a006957, XP055741986
OPPOSITION- R. Pelanda, R. M. Torres, "Central B- cell tolerance: where selection begins", Cold Spring Harbor Perspectives in Biology, (20120401), vol. 4, no. 4, page a007146, XP055741992
OPPOSITION- Daniela Fioretti, Sandra Iurescia, Vito Michele Fazio, Monica Rinaldi, "DNA vaccines: developing new strategies against cancer", J Biomed Biotechnol, (20100000), vol. 2010, pages 1 - 16, XP055741959
OPPOSITION- Matteo Vergati; Chiara Intrivici; Ngar-Yee Huen; Jeffrey Schlom; Kwong Y Tsang, "Strategies for Cancer Vaccine Development", J. Biomed. Biotechnol., (20111107), pages 1 - 13, XP055635230
OPPOSITION- Carosella Edgardo D; Favier Benoit; Rouas-Freiss Nathalie; Moreau Philippe; LeMaoult Joel, "Beyond the increasing complexity of the immunomodulatory HLA-G molecule", Blood, (20080000), vol. 111, no. 10, pages 4862 - 4870, XP008104444
OPPOSITION- CAROSELLA et al., "Beyond the increasing complexity of the immunomodulatory HLA-G molecule", Blood, (20080000), vol. 111, no. 10, doi:10.1182/BLOOD-2007-12-127662, pages 4862 - 4870, XP008104444
OPPOSITION- AGAUGUE, S. et al., "Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus TM/TM1", Blood, (20110000), vol. 117, no. 26, pages 7021 - 7031, XP002692762
OPPOSITION- Sophie Agaugué, Edgardo D. Carosella, and Nathalie Rouas-Freiss, "Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus Th1/Th17", Blood, (20110000), vol. 117, no. 26, pages 7021 - 7031, XP002692762
OPPOSITION- Sophie Agaugué, Edgardo D. Carosella, and Nathalie Rouas-Freiss, "Role of HLA-G in tumor escape through expansion of myeloid-derived suppressor cells and cytokinic balance in favor of Th2 versus Th1/Th17", Blood, (20111104), vol. 117, no. 2011, pages 7021 - 7031, XP002692762
OPPOSITION- Fadi Saade, Nikolai Petrovsky, "Technologies for enhanced efficacy of DNA vaccines", EXPERT REVIEW OF VACCINES, (20120200), vol. 11, no. 2, pages 189 - 209, XP055741965
OPPOSITION- Molek P., Tomaž Bratkovič, "Epitope mapping of mono- and polyclonal antibodies by screening phage-displayed random peptide libraries", Acta Chim. Slov., (20160000), vol. 63, no. 2016, pages 914 - 919, XP055746827
OPPOSITION- Loustau Maria, François Anna, Raphaelle Dréan, Martin Lecomte, Pierre Langlade-Demoyen, And Julien Caumartin, "HLA-G Neo-Expression on Tumors", Frontiers in Immunology, (20200814), vol. 11, no. 1685, pages 1 - 16, XP055746809
OPPOSITION- DESAI et al., "Structural relatedness of distinct determinants recognized by monoclonal antibody TP25.99 on beta 2-microglobulin-associated and beta 2-microglobulin-free HLA class I heavy chains", Journal of Immunology, (20000000), vol. 165, no. 6, pages 3275 - 3283, XP002692765
OPPOSITION- Pedro J. Morales, Judith L. Pace, Jeralyn Sue Platt, Teresa A. Phillips, Kim Morgan, Asgi T. Fazleabas and Joan S. Hunt, "Placental Cell Expression of HLA-G2 Isoforms Is Limited to the Invasive Trophoblast Phenotype", J. Immunol., (20030000), vol. 171, no. 11, pages 6215 - 6224, XP055746547

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents